PT1485084E - Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho - Google Patents

Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho

Info

Publication number
PT1485084E
PT1485084E PT03744341T PT03744341T PT1485084E PT 1485084 E PT1485084 E PT 1485084E PT 03744341 T PT03744341 T PT 03744341T PT 03744341 T PT03744341 T PT 03744341T PT 1485084 E PT1485084 E PT 1485084E
Authority
PT
Portugal
Prior art keywords
ascorbic acid
eye
improving
preparation
level
Prior art date
Application number
PT03744341T
Other languages
English (en)
Inventor
Mario Pinza
Durando Lucia
Marchitto Leonardo
Michele Virno
Original Assignee
Aziende C R Angelini Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende C R Angelini Francesco filed Critical Aziende C R Angelini Francesco
Publication of PT1485084E publication Critical patent/PT1485084E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT03744341T 2002-03-15 2003-03-05 Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho PT1485084E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000557A ITMI20020557A1 (it) 2002-03-15 2002-03-15 Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d

Publications (1)

Publication Number Publication Date
PT1485084E true PT1485084E (pt) 2006-08-31

Family

ID=11449521

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03744341T PT1485084E (pt) 2002-03-15 2003-03-05 Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho

Country Status (12)

Country Link
US (1) US20060004089A1 (pt)
EP (1) EP1485084B9 (pt)
AR (1) AR039604A1 (pt)
AT (1) ATE322262T1 (pt)
AU (1) AU2003210419A1 (pt)
CA (1) CA2476908A1 (pt)
DE (1) DE60304458T2 (pt)
DK (1) DK1485084T3 (pt)
ES (1) ES2260634T3 (pt)
IT (1) ITMI20020557A1 (pt)
PT (1) PT1485084E (pt)
WO (1) WO2003077905A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002582A2 (en) * 2006-06-27 2008-01-03 Riolan Technologies, Inc. Ultraviolet absorbing ophthalmic compositions
US10220012B2 (en) * 2016-06-03 2019-03-05 Joerg H. KRUMEICH Solution for ophthalmology
US20210128526A1 (en) * 2019-11-05 2021-05-06 Rajiv R. Mohan Eye drops to treat chemically induced corneal damage

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490389A (en) * 1976-03-11 1984-12-25 Nelson Research & Development Co. Contact lens preserving solution containing ascorbic acid or salts thereof
JPS5821614A (ja) * 1981-07-31 1983-02-08 Ss Pharmaceut Co Ltd 点眼剤
DE3133003A1 (de) * 1981-08-20 1983-03-10 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Mittel zur behandlung von truebungen im bereich des auges
US4886815A (en) * 1984-06-20 1989-12-12 Schachar Ronald A Treatment and prevention of retinal edema with dopaminergic antagonists
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
US5523316A (en) * 1994-06-23 1996-06-04 Alcon Laboratories, Inc. Intraocular irrigating solution containing agent for controlling IOP
IT1277707B1 (it) * 1995-12-22 1997-11-11 Chemedica Sa Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare
US5817630A (en) * 1997-03-18 1998-10-06 Austin Nutriceutical Corporation Glutathione antioxidant eye drops
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
WO2002001954A1 (en) * 2000-07-05 2002-01-10 The Board Of Trustees Of The University Of Arkansas Use of ascorbic acid and salts of ascorbic acid to promote cell repair and regeneration after injury

Also Published As

Publication number Publication date
EP1485084B1 (en) 2006-04-05
DE60304458D1 (de) 2006-05-18
ITMI20020557A0 (it) 2002-03-15
AR039604A1 (es) 2005-03-02
EP1485084A1 (en) 2004-12-15
EP1485084B9 (en) 2006-08-23
DK1485084T3 (da) 2006-07-31
ATE322262T1 (de) 2006-04-15
ITMI20020557A1 (it) 2003-09-15
DE60304458T2 (de) 2006-10-12
US20060004089A1 (en) 2006-01-05
ES2260634T3 (es) 2006-11-01
CA2476908A1 (en) 2003-09-25
WO2003077905A1 (en) 2003-09-25
AU2003210419A1 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
BRPI0514735B8 (pt) derivados de pirimidino sulfonamida como moduladores do receptor de quimiocina.
BRPI1006115A8 (pt) "agentes indutores de apoptose para o tratamento de câncer e doenças autoimunes".
CL2003002683A1 (es) Enantiomeros s de compuestos derivados del acido (2s)-3-4(-{2-amino-2-oxoetoxi}fenil)-2-etoxipropanoico; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para el tratamiento o prevencion de trastornos de lipidos,
EP1598371A4 (en) THERAPEUTIC COMPOSITION FOR OPHTHALMIC USE CONTAINING ACETYL HYALURONIC ACID
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
WO2004072085A3 (de) Salz einer sulfonsäure mit clopidogrel und dessen verwendung zur herstellung pharmazeutischer formulierungen
EP2650293A8 (en) [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
BRPI0518993A2 (pt) composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
BRPI0606606A2 (pt) composições estáveis contendo prostaglandina
TW200606164A (en) New compounds
IL198180A (en) Salt p- toluene 5-amino-3-sulfonic acid (2'-0-acetyl-3'-deoxy-ß-d-riboforanosyl) -3h-thiazole [5,4- d] pyrimidine-2-on crystalline form , A pharmaceutical product containing it, its use in the preparation of a drug and methods for its manufacture
RS54050B1 (en) FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS
TW200800984A (en) New compounds
AR029412A1 (es) Forma cristalina
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
NO20092764L (no) Isosorbid mononitrat derivater for behandling av okular hypertensjon
PT1485084E (pt) Utilizacao de um sal de acido l-ascorbico para a preparacao de uma composicao farmaceutica para a utilizacao topica oftalmologica capaz de melhorar o nivel de acido l-ascorbico no olho
WO2005070903A3 (en) Sulphonamide substituted triazines as chemokine receptor modulators
EP2722322B8 (en) 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
ATE385786T1 (de) Pharmazeutische zusammensetzung in form eines hydrogels zur transdermalen verabreichung von wirkstoffen
BRPI0720089A2 (pt) Uso de l-carnitina para a preparação de um medicamento na forma de colírio para o tratamento de doenças da córnea
IL182835A0 (en) Process for and imtermediates in the preparaition of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents
BRPI0115076B8 (pt) preparação farmacêutica, sua aplicação farmacêutica, bem como processo para preparação da mesma
SI1485084T1 (sl) Uporaba soli L-asklorbinske kisline za pripravo farmacevtskega sestavka za oftalmicno topikalno uporabo, ki ima sposobnost izboljsati nivo L-askorbinske kisline v ocesu
BRPI0412453A (pt) uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo